Jim Cramer Says He Can’t Recommend This Major Automaker, Ceva Is ‘Way Too High’

Avi Kapoor | November 5, 2024

On CNBC’s “Mad Money Lightning Round,” Jim Cramer said Ceva (NYSE:CEVA) is “way too high, and I think you should take something off the table.” Ceva will announce results for the third quarter on Nov. 7, 2024, before the opening bell. “I love space stuff, and that’s why I keep recommending Tesla (NASDAQ:TSLA),” Cramer said […]

Top 2 Industrials Stocks That May Crash In Q4

Avi Kapoor | October 11, 2024

As of Oct. 11, 2024, two stocks in the industrials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go […]

Top 2 Defensive Stocks That May Crash In October

Avi Kapoor | October 7, 2024

As of Oct. 7, 2024, two stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices […]

This Morgan Stanley Analyst Turns Bullish; Here Are Top 5 Upgrades

Avi Kapoor | October 4, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HSBC analyst Saul Martinez upgraded Morgan Stanley (NYSE:MS) from Hold to Buy and announced a price target of $118. Morgan Stanley shares gained 0.1% to […]

This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Avi Kapoor | September 27, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wolfe Research analyst Andy Chen downgraded the rating for Celldex Therapeutics, Inc. (NASDAQ:CLDX) from Outperform to Peer Perform. Celldex Therapeutics shares fell 8.7% to close […]

Wall Street’s Most Accurate Analysts Spotlight On 3 Energy Stocks With Over 5% Dividend Yields

Avi Kapoor | September 18, 2024

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through […]

Domino’s Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor | September 11, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Ascendiant Capital raised the price target for Atossa Therapeutics, Inc. (NASDAQ:ATOS) from $6.25 to $6.5. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Atossa […]

Here Are 5 Stock Picks for August from Wall Street’s Most Accurate Analysts

Avi Kapoor | September 9, 2024

U.S. stocks settled lower on Friday, with the S&P 500 logging its worst week since March 2023. The S&P 500 fell 1.73% to 5,408.42 during the session. Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when […]

Nasdaq Dips Over 2%; US Construction Spending Falls In July

Avi Kapoor | September 3, 2024

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 1% on Tuesday. The Dow traded down 0.94% to 41,173.76 while the NASDAQ fell 2.22% to 17,320.89. The S&P 500 also fell, dropping, 1.28% to 5,575.91. Check This Out: Dow Hits Record High, S&P 500 Gains For 4th Consecutive Month: Fear […]

Next Page »